AJANTA PHARMA
Quarterly Results Analysis [Dec2023]
AJANTA PHARMA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,105 Cr | ₹1,028 Cr | ₹1,021 Cr | ₹882 Cr | ₹972 Cr | ₹938 Cr | ₹951 Cr | ₹870 Cr |
Expenses | ₹791 Cr | ₹738 Cr | ₹750 Cr | ₹732 Cr | ₹802 Cr | ₹742 Cr | ₹729 Cr | ₹664 Cr |
Operating Income | ₹314 Cr | ₹291 Cr | ₹271 Cr | ₹149 Cr | ₹170 Cr | ₹196 Cr | ₹222 Cr | ₹207 Cr |
Other Income | ₹14 Cr | ₹21 Cr | ₹32 Cr | ₹37 Cr | ₹35 Cr | ₹40 Cr | ₹33 Cr | ₹29 Cr |
Interest | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹7 Cr |
Depreciation | ₹34 Cr | ₹34 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹32 Cr | ₹31 Cr |
Profit Before Tax | ₹291 Cr | ₹276 Cr | ₹269 Cr | ₹152 Cr | ₹168 Cr | ₹203 Cr | ₹222 Cr | ₹198 Cr |
Profit After Tax | ₹210 Cr | ₹195 Cr | ₹208 Cr | ₹122 Cr | ₹135 Cr | ₹157 Cr | ₹175 Cr | ₹151 Cr |
EPS | ₹16.62 | ₹15.46 | ₹16.47 | ₹9.68 | ₹10.46 | ₹12.18 | ₹13.58 | ₹11.74 |
Industry Peers & Returns | 1W | 1M | 1Y |
AJANTA PHARMA | 5.4% | 4.4% | 78.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
AJANTA PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 7.46 % |
Y-o-Y | 13.73 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹1,105 Cr | 7.46 | |
Sep2023 | ₹1,028 Cr | 0.72 | |
Jun2023 | ₹1,021 Cr | 15.79 | |
Mar2023 | ₹882 Cr | -9.25 | |
Dec2022 | ₹972 Cr | 3.59 | |
Sep2022 | ₹938 Cr | -1.35 | |
Jun2022 | ₹951 Cr | 9.27 | |
Mar2022 | ₹870 Cr | - |
AJANTA PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 8.05 % |
Y-o-Y | 85.24 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹314 Cr | 8.05 | |
Sep2023 | ₹291 Cr | 7.13 | |
Jun2023 | ₹271 Cr | 81.64 | |
Mar2023 | ₹149 Cr | -11.90 | |
Dec2022 | ₹170 Cr | -13.64 | |
Sep2022 | ₹196 Cr | -11.46 | |
Jun2022 | ₹222 Cr | 7.29 | |
Mar2022 | ₹207 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.57 % |
Y-o-Y | 62.87 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 28.42% | 0.57 | |
Sep2023 | 28.26% | 6.36 | |
Jun2023 | 26.57% | 56.85 | |
Mar2023 | 16.94% | -2.92 | |
Dec2022 | 17.45% | -16.63 | |
Sep2022 | 20.93% | -10.25 | |
Jun2022 | 23.32% | -1.81 | |
Mar2022 | 23.75% | - |
AJANTA PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 7.54 % |
Y-o-Y | 56.14 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹210 Cr | 7.54 | |
Sep2023 | ₹195 Cr | -6.16 | |
Jun2023 | ₹208 Cr | 70.24 | |
Mar2023 | ₹122 Cr | -9.11 | |
Dec2022 | ₹135 Cr | -14.11 | |
Sep2022 | ₹157 Cr | -10.32 | |
Jun2022 | ₹175 Cr | 15.48 | |
Mar2022 | ₹151 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 0.05 % |
Y-o-Y | 37.28 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 19 % | 0.05 | |
Sep2023 | 18.99 % | -6.82 | |
Jun2023 | 20.38 % | 47.04 | |
Mar2023 | 13.86 % | 0.14 | |
Dec2022 | 13.84 % | -17.08 | |
Sep2022 | 16.69 % | -9.10 | |
Jun2022 | 18.36 % | 5.70 | |
Mar2022 | 17.37 % | - |
AJANTA PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 7.50 % |
Y-o-Y | 58.89 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹16.62 | 7.50 | |
Sep2023 | ₹15.46 | -6.13 | |
Jun2023 | ₹16.47 | 70.14 | |
Mar2023 | ₹9.68 | -7.46 | |
Dec2022 | ₹10.46 | -14.12 | |
Sep2022 | ₹12.18 | -10.31 | |
Jun2022 | ₹13.58 | 15.67 | |
Mar2022 | ₹11.74 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD